Research:

Overview

Our drug discovery programs are based on creating novel compounds based on synthetic DNA and RNA. We are employing two scientific approaches with a goal of creating novel drug candidates:

First approach involves creating compounds to modulate immune responses through endosomal Toll-like Receptors 3, 7, 8, and 9.

Second approach involves gene-silencing leading to inhibition of expression of disease-associated proteins.

Idera has a successful track record of novel discoveries which have resulted in hundreds of peer-reviewed publications and a strong patent portfolio.